Literature DB >> 23049344

Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant.

Luciana Cristina Fagundes Gequelin1, Irina N Riediger, Sueli M Nakatani, Alexander W Biondo, Carmem M Bonfim.   

Abstract

The Epstein-Barr virus is responsible for infectious mononucleosis syndrome and is also closely associated to several types of cancer. The main complication involving Epstein-Barr virus infection, both in recipients of hematopoietic stem cells and solid organs, is post-transplant lymphoproliferative disease. The importance of this disease has increased interest in the development of laboratory tools to improve post-transplant monitoring and to detect the disease before clinical evolution. Viral load analysis for Epstein-Barr virus through real-time polymerase chain reaction is, at present, the best tool to measure viral load. However, there is not a consensus on which sample type is the best for the test and what is its predictive value for therapeutic interventions.

Entities:  

Keywords:  Herpesvirus 4, human; Lymphoproliferative disorders; Polymerase chain reaction; Transplantation

Year:  2011        PMID: 23049344      PMCID: PMC3415781          DOI: 10.5581/1516-8484.20110103

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


  69 in total

1.  Epstein-Barr virus (EBV)-DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease.

Authors:  Arjan C Lankester; Maarten J D van Tol; Jaak M Vossen; Aloys C M Kroes; Eric Claas
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

2.  Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis.

Authors:  Tomoko Teramura; Yasuhiro Tabata; Tomohito Yagi; Akira Morimoto; Shigeyoshi Hibi; Shinsaku Imashuku
Journal:  Leuk Lymphoma       Date:  2002-01

Review 3.  How I treat EBV lymphoproliferation.

Authors:  Helen E Heslop
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113

4.  Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.

Authors:  Servi J C Stevens; Sandra A W M Verkuijlen; Bambang Hariwiyanto; Jajah Fachiroh; Dewi K Paramita; I Bing Tan; Sophia M Haryana; Jaap M Middeldorp
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 5.  Post-transplant lymphoproliferative disorder in children: incidence, prognosis, and treatment options.

Authors:  Albert Faye; Etienne Vilmer
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood.

Authors:  E Leung; B K Shenton; G Jackson; F K Gould; C Yap; D Talbot
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

Review 7.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

Review 8.  Epstein-Barr virus: the impact of scientific advances on clinical practice.

Authors:  Hilary Williams; Dorothy H Crawford
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

Review 9.  Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.

Authors:  D M Weinstock; G G Ambrossi; C Brennan; T E Kiehn; A Jakubowski
Journal:  Bone Marrow Transplant       Date:  2006-03       Impact factor: 5.483

Review 10.  Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.

Authors:  Servi J C Stevens; Erik A M Verschuuren; Sandra A W M Verkuujlen; Adriaan J C Van Den Brule; Chris J L M Meijer; Jaap M Middeldorp
Journal:  Leuk Lymphoma       Date:  2002-04
View more
  4 in total

1.  The Epstein-Barr virus LMP1 interactome: biological implications and therapeutic targets.

Authors:  Mujeeb R Cheerathodi; David G Meckes
Journal:  Future Virol       Date:  2018-12-03       Impact factor: 1.831

Review 2.  Epstein-Barr virus and skin.

Authors:  Martin Sangueza-Acosta; Erica Sandoval-Romero
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

Review 3.  Molecular Genetics in Epstein-Barr Virus-Associated Malignancies.

Authors:  Srikanth Umakanthan; Maryann M Bukelo
Journal:  Life (Basel)       Date:  2021-06-22

4.  Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease.

Authors:  Sirine Andari; Hadi Hussein; Sukayna Fadlallah; Abdo R Jurjus; Margret Shirinian; Jana G Hashash; Elias A Rahal
Journal:  Viruses       Date:  2021-06-29       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.